SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-17-051038
Filing Date
2017-08-10
Accepted
2017-08-10 16:02:56
Documents
4
Effectiveness Date
2017-08-10

Document Format Files

Seq Description Document Type Size
1 S-8 a17-18758_2s8.htm S-8 91465
2 EX-5.1 a17-18758_2ex5d1.htm EX-5.1 8090
3 EX-10.1 a17-18758_2ex10d1.htm EX-10.1 38213
4 EX-23.1 a17-18758_2ex23d1.htm EX-23.1 3639
  Complete submission text file 0001104659-17-051038.txt   142627
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-219867 | Film No.: 171021455
SIC: 2835 In Vitro & In Vivo Diagnostic Substances